Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.
- Published In:
- Obstetrics and gynecology, 134(5), 909-917 (2019)
- Authors:
- Simon, James A, Kingsberg, Sheryl A, Portman, David, Williams, Laura A, Krop, Julie, Jordan, Robert, Lucas, Johna, Clayton, Anita H
- Database ID:
- RPEP-04485
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04485APA
Simon, James A; Kingsberg, Sheryl A; Portman, David; Williams, Laura A; Krop, Julie; Jordan, Robert; Lucas, Johna; Clayton, Anita H. (2019). Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.. Obstetrics and gynecology, 134(5), 909-917. https://doi.org/10.1097/AOG.0000000000003514
MLA
Simon, James A, et al. "Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.." Obstetrics and gynecology, 2019. https://doi.org/10.1097/AOG.0000000000003514
RethinkPeptides
RethinkPeptides Research Database. "Long-Term Safety and Efficacy of Bremelanotide for Hypoactiv..." RPEP-04485. Retrieved from https://rethinkpeptides.com/research/simon-2019-longterm-safety-and-efficacy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.